MesoCyto Study

A multicenter, prospective feasibility study for definite diagnosis of malignant pleural mesothelioma by pleural effusion cytopathology - Definite Diagnosis of Mesothelioma by Pleural Effusion Cytopathology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038709

Enrollment

100

Registered

2019-11-28

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Pleural Mesothelioma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)untreated 2)supicious with malignant pleural mesothelioma based on radiological findings 3)pleural effusion examination and pleural biopsy are needed to obtain definitive diagnosis 4)pleurocentesis could be safety done 5)pleural biopsy under general anesthesia could be safety done 6)adult 7)written informed concent of this study

Exclusion criteria

Exclusion criteria: 1)pleural biopsy was already done prior to this study 2)complicated other malignancies 3)complicated other intrathoracic disease(empyema, pleuritis)

Design outcomes

Primary

Measure	Time frame
Diagnostic specificity of pleural effusion examination	—

Secondary

Measure	Time frame
Positive predictive value of cytology and diagnostic concordance rates by histological subtype of MPM (epithelial, biphasic, and sarcomatous)	—

Countries

Japan

Contacts

Public ContactMasaki Hashimoto

Hyogo College of Medicine Department of Thoracic Surgery

kogekogemasaki@gmail.com0798-45-6885

Outcome results